KBR Building Group Awarded Contract for Medicago’s Vaccine Research & Production Facility/Greenhouse in Research Triangle P...

KBR (NYSE: KBR) today announced that its Building Group has been awarded a contract by Alexandria Real Estate Equities for the construction of Medicago’s new 90,000-square-foot Vaccine Research and Production Facility/Greenhouse in Research Triangle Park, N.C. The contract is valued at approximately $19 million. Site work is underway.

Medicago’s plant-based commercial grade vaccines facility will include an automated greenhouse, extensive laboratory, production facility and office space with the project’s total investment expected to exceed $32 million. Scheduled for completion in July 2011, the project is being managed from the Building Group’s Raleigh office. The project has received substantial federal funding from the Defense Advanced Research Projects Agency (DARPA) through a $21 million research grant to improve the process of producing large quantities of H1N1 vaccine.

“The Building Group is well known for its strong history in the construction of advanced research and development facilities, with an emphasis on vaccine production facilities,” said Luther Cochrane, Senior Vice President, KBR and Chairman of the Building Group. “I am confident that our team’s specialized expertise will serve the Medicago project well and lead us to another successful project completion in Research Triangle Park.”

KBR is a global engineering, construction and services company supporting the energy, hydrocarbon, government services, minerals, civil infrastructure, power and industrial markets. For more information, visit www.kbr.com.